Efficacy and Safety of Afatinib in the Treatment of Advanced Non-Small-Cell Lung Cancer with EGFR Mutations: A Meta-Analysis of Real-World Evidence.

Zhang, Lemeng; Luo, Yongzhong; Chen, Jianhua; Cheng, Tianli; Yang, Hua; Pan, Changqie; Li, Haitao; Jiang, Zhou

Zhang, Lemeng; Luo, Yongzhong; Chen, Jianhua; Cheng, Tianli; Yang, Hua; Pan, Changqie; Li, Haitao; Jiang, Zhou.

Afiliación

Zhang L; Thoracic Medicine Department 1, Hunan Cancer Hospital, Changsha 410013, Hunan Province, China.
Luo Y; Thoracic Medicine Department 1, Hunan Cancer Hospital, Changsha 410013, Hunan Province, China.
Chen J; Thoracic Medicine Department 1, Hunan Cancer Hospital, Changsha 410013, Hunan Province, China.
Cheng T; Thoracic Medicine Department 1, Hunan Cancer Hospital, Changsha 410013, Hunan Province, China.
Yang H; Thoracic Medicine Department 1, Hunan Cancer Hospital, Changsha 410013, Hunan Province, China.
Pan C; Thoracic Medicine Department 1, Hunan Cancer Hospital, Changsha 410013, Hunan Province, China.
Li H; Thoracic Medicine Department 1, Hunan Cancer Hospital, Changsha 410013, Hunan Province, China.
Jiang Z; Thoracic Medicine Department 1, Hunan Cancer Hospital, Changsha 410013, Hunan Province, China.

J Oncol ; 2021: 8736288, 2021.

Article en En | MEDLINE | ID: mdl-34961817

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies / Qualitative_research / Systematic_reviews Idioma: En Revista: J Oncol Año: 2021 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google